Pay in 4 interest-free payments of $16.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
pan FGFR kinase inhibitor BGJ398 selectively binds to and inhibits the activities of FGFRs
inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis
and effective growth suppression by small molecular inhibitors in kidney cancer cells
and a decreased response to chemotherapy
TZ9 - Rad6 Ubiquitin Inhibitor. CAS# 1002789-86-7 size:10mg solid Small-molecule inhibition of MLL activityTZ9, CAS No. 1002789 86 7, is a selective and cell permeable inhibitor of human E2 ubiquitin conjugating enzyme Rad6B. It binds to the Rad6B catalytic site, inhibits Rad6B induced histone H2A ubiquitination, downregulates intracellular catenin. It can induce G2 M arrest and apoptosis, and inhibit proliferation and migration of metastatic human breast cancer cells (IC50 ~6 M). Product information CAS Number: 1002789 86 7 Molecular Weight: 366. 33
US$ 155.00
US$ 145.00
US$ 85.00
US$ 15.00
US$ 55.00
US$ 20.00